- A total of 14 PUERTA participating sites, 12 US and 2 Australian, in the Phase 2A trial of ALT-100 mAb in moderate to severe ARDS
- Aqualung awarded a $3M NIH R44 grant supporting the PUERTA Phase 2A Clinical Trial
Author Archive: AZBioPEERS Team
Opportunity Alert: Traction Accelerator (Apply by December 15th)
Are you an entrepreneur ready to grow your revenue? Join the Traction Accelerator and get the tools, training, and community you need to rapidly grow your business.
The Traction Accelerator is a 19-week intensive program with 7 months of mentoring that will help you identify your ideal customers, craft messaging that converts, build sales systems that scale, and create momentum for your startup.
You’ll get access to top-tier mentors, and a network of like-minded founders facing similar challenges. Walk away with a clear plan to acquire customers and generate revenue. CEI is so confident this program will accelerate your startup’s growth that if you complete the program and don’t increase your revenue, they’ll refund your money.
Applications for Traction Accelerator close December 15th!
Learn more and apply here: ceigateway.com/traction-accelerator/
For additional information, contact Patti DuBois at dubois@ceigateway.com
HonorHealth Research Institute clinical trial helps secure FDA approval of revolutionary new pacemaker
SCOTTSDALE, Ariz. — Sept. 19, 2023 — HonorHealth Research Institute is ushering in a new era of heart pacemakers for patients with abnormal or slow heart rhythms by helping secure FDA approval of the world’s first dual chamber leadless pacemaker.Continue reading
Mayo Clinic appoints Victor Ortega, M.D., associate director of Center for Individualized Medicine
PHOENIX, Ariz. — Victor Ortega, M.D., Ph.D., has been named associate director of Mayo
Clinic’s Center for Individualized Medicine in Arizona.Continue reading
Mayo Clinic appoints Bhavik Patel, M.D., chief AI officer
PHOENIX, Ariz. — Bhavik Patel, M.D., has been appointed chief artificial intelligence (AI) officer for Mayo Clinic in Arizona. In this role, Dr. Patel will lead Mayo Clinic’s Advanced AI and Innovation Hub in Arizona with a focus on expanding AI-based solutions within Mayo’s three shields of Practice, Research and Education, in addition to business operations. Continue reading
City of Hope scientists develop targeted chemotherapy able to kill all solid tumors in preclinical research
The City of Hope-developed investigational small molecule selectively disrupts DNA replication and repair in cancer cells, leaving healthy cells unaffected, a new study reports.Continue reading
New UArizona study links brain waves directly to memory
The findings could lay foundations for cognitive impairment therapy and help improve memory.Continue reading
TGen appoints J. Gregory Caporaso, Ph.D., Professor in its Pathogen and Microbiome Division
Flagstaff, Arizona — July 25, 2023 — The Translational Genomics Research Institute (TGen), part of City of Hope, today announced that J. Gregory Caporaso, Ph.D., has joined the Institute as a Professor in its pathogen and microbiome division located in Flagstaff, more commonly known as TGen North. Continue reading
IdeaFunding Returns to TENWEST Impact Festival in 2023 to Showcase Innovation and Entrepreneurship – Applications Launch for Pitch Competition with over $70,000 in Prizes
July 24, 2023 (Tucson, Ariz.) – Applications for the 2023 IdeaFunding competition are live and startups can submit applications before August 28, 2023. IdeaFunding is Southern Arizona’s largest and longest entrepreneurial conference and pitch competition, where this year over $70,000 in prize funding will be awarded to Arizona companies. IdeaFunding is co-led by Startup Tucson and the University of Arizona Center for Innovation (UACI) and presented by the Arizona Commerce Authority. Continue reading
Erroneous genetic sequences identified for the first time in specific cells of ALS and frontotemporal dementia patients
Gene splicing defect known as “cryptic exons” detected using single-nuclei RNA sequencingContinue reading